IDiyas

For the Inventor, By the Inventor

Al-Ahsa, Saudi Arabia

Osama I Alwassil

USPTO Granted Patents = 8

Average Co-Inventor Count = 7.7

ph-index = 1


Location History:

  • Riyadh, SA (2024)
  • Al-Ahsa, SA (2024)

Company Filing History:

goldMedal8 out of 3,201 
 
King Fahd University of Petroleum and Minerals
 patents

Years Active: 2024

Loading Chart...
8 patents (USPTO):Explore Patents
1. 12172973 - (E)-2-(3-Cyano-4-isobutoxyphenyl)-N'-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agents (2024-12-24),
2. 12145915 - (E)-2-(3-cyano-4-isobutoxyphenyl)-n'-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agents (2024-11-19),
3. 11986476 - (6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones as antitubercular agents (2024-05-21),
4. 11981674 - 7-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as larvicidal agents (2024-05-14),
5. 11970489 - 4-[(substituted 1H-benzimidazol-2-ylsulfanyl)methyl]-6-substituted-2H-chromen-2-ones as larvicidal agents (2024-04-30),
6. 11945819 - Dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agents (2024-04-02),
7. 11939294 - 1-(2-(substituted phenyl)-2-oxoethyl)-3,5-dimethylpyridin-1-ium bromides as antitubercular agents (2024-03-26),
8. 11912683 - (6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones as antitubercular agents (2024-02-27),

Title: The Innovative Contributions of Osama I Alwassil

Introduction

Osama I Alwassil is a prominent inventor based in Al-Ahsa, Saudi Arabia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tubercular agents. With a total of eight patents to his name, Alwassil's work is recognized for its innovative approach to combating tuberculosis.

Latest Patents

Among his latest patents, Alwassil has developed (E)-2-(3-Cyano-4-isobutoxyphenyl)-N'-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides, which are novel arylhydrazones derivatives. These compounds are synthesized through a specific method and are formulated into a pharmaceutical composition that includes a suitable carrier. The arylhydrazones derivative compounds are particularly useful as anti-tubercular agents, showcasing Alwassil's commitment to addressing critical health challenges.

Career Highlights

Osama I Alwassil is affiliated with King Fahd University of Petroleum and Minerals, where he continues to engage in research and development. His academic and professional background has equipped him with the skills necessary to innovate in the pharmaceutical sector. His contributions have not only advanced scientific knowledge but also provided potential solutions for public health issues.

Collaborations

Alwassil has collaborated with notable colleagues, including Katharigatta N Venugopala and Mohamed A Morsy. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Osama I Alwassil's work exemplifies the spirit of innovation in the field of pharmaceuticals. His patents and research efforts contribute significantly to the fight against tuberculosis, highlighting the importance of continued research and collaboration in addressing global health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…